Hypoxic-Ischemic Encephalopathy and Serum Magnesium Monitoring and Maintenance

  title={Hypoxic-Ischemic Encephalopathy and Serum Magnesium Monitoring and Maintenance},
  author={Susan Givens Bell},
  journal={Neonatal Network},
  pages={159 - 163}
ABSTRACT Magnesium plays important roles in many physiologic functions including protein synthesis, bone development, and cell membrane function. There is some evidence to suggest a role for magnesium sulfate as a therapeutic neuroprotective agent along with therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy, but studies are inconclusive. Ischemic insult and hypothermia may both play a role in altered magnesium levels in this population. 
5 Citations
A randomized controlled trial on the use of magnesium sulfate and melatonin in neonatal hypoxic ischemic encephalopathy.
MgSO4 may have an added effect for the reduction in brain injury in infants with HIE who are receiving melatonin in a randomized controlled trial on infants with moderate HIE.
System Specific Effects of Therapeutic Hypothermia with Neonatal Encephalopathy: Pearls for Clinicians
There is a paucity of literature that comprehensively identifies causal relationships between the physiologic and biochemical effects of Therapeutic hypothermia, which can leave neonatal clinicians devoid of a comprehensive understanding of the medical management of NE.
Vitamin D as an Adjuvant Therapy in Neonatal Hypoxia: Is it Beneficial?
Vitamin D was found to improve the cases of group I as demonstrated by the reduction of serum S100-B levels after vitamin D therapy.
Akut İnmede Risk Faktörü ve Prognoz Üzerine Etkisi ile Magnezyum
Bu calisma ile serebrovaskuler olayda magnezyumun degistirilebilir bir risk faktoru olarak degerlendirilmesi ve mortalite uzerine etkisinin olup olmadiginin arastirilmasi planlandi dikkat cekici bir ozellikti.


Neonatal therapeutic hypothermia-associated hypomagnesemia during parenteral nutrition therapy.
Serum magnesium was depressed in 80% of the infants cooled despite administration of standard PN and required additional magnesium supplementation and further studies are needed to determine the target magnesium required for PN in hypothermic therapy.
Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate
Whether postnatal MgSO4 infusion is safe in infants with severe birth asphyxia, and also observe effects on neurodevelopmental outcome at 18 months is determined.
Magnesium for neuroprotection in birth asphyxia
Magnesium is well tolerated and does appear to have beneficial effects in babies with severe asphyxia, however more data is however needed and a large multicenter trial should be conducted.
Hypoxic-ischemic encephalopathy: a review for the clinician.
The pathophysiology of HIE is now better understood, and treatment withHypothermia has become the foundation of therapy, and several neuroprotective agents offer promise when combined with hypothermia and are entering clinical trials.
Excitotoxicity in neonatal hypoxia.
  • M. Johnston
  • Biology
    Mental retardation and developmental disabilities research reviews
  • 2001
Understanding the complex molecular networks triggered by an excitotoxic insult in the neonate provides insight into patterns of selective neuronal vulnerability and potential therapeutic strategies.
Multicenter Randomized Controlled Trial of Therapeutic Hypothermia Plus Magnesium Sulfate Versus Therapeutic Hypothermia Plus Placebo in the Management of Term and Near‑term Infants with Hypoxic Ischemic Encephalopathy (The Mag Cool Study): A Pilot Study
The combined use of therapeutic hypothermia and MgSO4 appears to be safe particularly with respect to maintaining normal blood pressure and coagulopathy.
Clinical applications of induced hypothermia
Hypothermia, defined as a core temperature <35 C, is a treatment for medical conditions and in certain critical care patient groups, it has demonstrable effects on improving patient outcome.
Glutamate uptake
Medication use in the neonatal intensive care unit.
Medication use in the NICU has changed substantially over time, and only 35% of the most commonly prescribed medications are Food and Drug Administration -approved in infants.
Magnesium gates glutamate-activated channels in mouse central neurones
The voltage dependence of the NMDA receptor-linked conductance appears to be a consequence of the voltage dependenceof the Mg2+ block and its interpretation does not require the implication of an intramembrane voltage-dependent ‘gate’.